Back to
Qube Research & Technologies Ltd
ALPN8 quarters
Position history for
Qube Research & Technologies Ltd's holdings in ALPINE IMMUNE SCIENCES INC
As of its Q1 2024 13F, Qube Research & Technologies held 163,323 shares of ALPN (Alpine Immune Sciences), worth $6.5M. Qube Research & Technologies' 13F filings listed ALPN from Q3 2023 to Q1 2024, 3 quarterly filings.
Final Value
$0
Final Shares
0
Total Value Change
-$329,000
Total Shares Change
-37,377
Quarter-by-Quarter History
Other major holders of ALPN: Avoro Capital Advisors LLC, BlackRock Finance, Inc., PRICE T ROWE ASSOCIATES INC /MD/, STATE STREET CORP, RA CAPITAL MANAGEMENT, L.P.